MedPath
NMPA Approval

Lenvatinib Mesilate Capsules

国药准字H20253102

January 8, 2025

Drug Information

甲磺酸仑伐替尼胶囊

胶囊剂

4mg(按C₂₁H₁₉ClN₄O₄计)

化学药品

January 8, 2025

Company Information

Applicant Company

吉林省洮南经济开发区兴业路2999号

Manufacturing Company

吉林省洮南经济开发区兴业路2999号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸仑伐替尼胶囊 - NMPA 批准文号 | MedPath